2009

Becker C, Stichtenoth D, Wichmann M, Schaefer C, Szinicz L.
Blood donors on medication. An approach to minimize drug burden for recipients of blood products and to limit deferral of donors.
Transfus Med Hemother 2009; 36: 107-13.

Clementi M, Cassina M, Di Gianantonio E.
Medications in Pregnancy and lactation.
Obstetrics and Gynecology, 2009; 114:166.

De Santis M, Di Gianantonio E, Cesari E, Ambrosiani G, Straface G, Clementi M.
First-trimester Itraconazole Exposure and pregnancy outcome. A prospective cohort study of women contacting teratology Information Services in Italy.
Drug Safety 2009; 32: 239-44

Schaefer C, Meister R, Weber-Schoendorfer C.
Isotretinoin exposure and pregnancy outcome- an observational study of the Berlin institute for clinical teratology and drug risk assessment during pregnancy.
Arch Gynecol Obstet 2009; DOI: 10.1007/s00404-009-1112-2.

Schaefer C, Meister R, Wentzeck R, Weber-Schoendorfer C.
Fetal outcome after technetium scintigraphy in early pregnancy.
Reprod Toxicol 2009; 28. DOI: 10.1016/j.reprotox.2009.05.001.

Weber-Schoendorfer C, Schaefer C.
Multiple Sclerosis, Immunomodulators and Pregnancy Outcome.A prospective observational study.
Mult Scler 2009 (accepted).

Jürgens T, Schaefer C, May A.
Treatment of cluster headache in pregnancy and lactation.
Cephalalgia 2009; Jan 19. [Epub ahead of print] PMID: 19170693

2008

Clementi M, Tiboni GM, Causin R, La Rocca C, Maranghi F , Raffagnato F, Tenconi R
Pesticides and Fertility: an Epidemiological Study in Northeast Italy and Review of the Literature
Reproductive Toxicology. Reproductive Toxicology. 2008; 26:13–18

Diav-Citrin O, Shechtman S, Weinbaum D, Wajnberg R, Avgil M, Di Gianantonio E, Clementi M, Weber-Schoendorfer C, Schaefer C, Ornoy A
Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study.
British Journal of Clinical Pharmacology, 2008; 66: 695-705

Hoeltzenbein M, Weber-Schoendorfer C, v. Stackelberg L, Schaefer C
Paternal exposure to drugs – Is there an increased risk for congenital abnormalities? Experience of the Berlin Institute of Clinical Teratology and Drug Risk Assessment during Pregnancy (Abstract).
Med Genetik 2008; 20:166.

Hoeltzenbein M, Weber-Schoendorfer C, v. Stackelberg L, Schaefer C
Paternal exposure to drugs – Is there an increased risk for congenital abnormalities? : Experience of the Berlin Institute for Clinical Teratology and Drug Risk Assessment during Pregnancy.
Reprod Toxicol 2008; 26: 64.

Jürgens T, Schaefer C, May A.
Treatment of cluster headache in pregnancy and lactation.
Cephalalgia 2008 (in press).

Martínez-Frías ML, Bermejo E, Rodriguez-Pinilla E, Prieto D y Grupo de trabajo del ECEMC.
Does single umbilical artery (SUA) predict any type of congenital defect? Clinical-epidemiological analysis of a large consecutive series of malformed infants.
Am J Med Genet (Part A ) 2008; 146 (1): 26-34.

Martínez-Frías ML, Rodríguez Pinilla E.
Problem of using cases with genetic anomalies as a reference group in case-control studies on drug use and birth defects.
Birth Defects Res A Clin Mol Teratol 2008; 82 (3): 173-174. (author replay 175).

Meister R, Schaefer C.
Statistical methods for estimating the probability of spontaneous abortion in observational studies - Analyzing pregnancies exposed to coumarin derivatives.
Reprod Toxicol 2008; 26:31-5.

Padberg S, Weber-Schoendorfer C, Schaefer C.
Lamotrigine during lactation (Abstract)
Reprod Toxicol 2008; 26:70-1

Rodríguez-Pinilla E, Mejías C, Prieto-Merino D, Fernández P, Martínez-Frías ML.
Risk of Hypospadias in Newborn Infants exposed to valproic acid during the first trimester of pregnancy. A case-control Study in Spain.
Drug Safety 2008; 31(6):537-543.

Schaefer C, Ornoy A, Clementi M, Meister R, Weber-Schoendorfer C
Using observational cohort data for studying drug effects on pregnancy Outcome - Methodological considerations.
Reprod Toxicol 2008; 26:36-41.

Weber-Schoendorfer C, Schaefer C.
Monoclonal antibody therapy during pregnancy – Experience of the Berlin Teratology Information Service.
Reprod Toxicol 2008; 26:75

Weber-Schoendorfer C, Schaefer C.
Multiple sclerosis – effects of immunomodulatory therapy on pregnancy outcome: An observational study of the Teratology Information Service Berlin, Germany.
Birth Def Res A 2008; 82:298

Weber-Schoendorfer C, Schaefer C
Trastuzumb exposure during pregnancy.
Reprod Toxicol 2008; 25:390-1

Wentges-van Holthe N, van Eijkeren M, van der Laan JW
Oseltamivir and breastfeeding
International Journal of Infectious Diseases. In Press Available online 1 February 2008

Weber-Schoendorfer C, Hannemann D, Meister R, Eléfant E, Cuppers-Maarschalkerweerd B, Arnon J, Vial T, Rodriguez-Pinilla E, Clementi M, Robert-Gnansia E, De Santis M, Malm H, Dolivo A, Schaefer C
The safety of calcium channel blockers during pregnancy: A prospective, multicenter, observational study.
Reprod Toxicol 2008; 26:24-30.

Weber-Schoendorfer C, Schaefer C.
The safety of cetirizine during pregnancy A prospective observational cohort study.
Reprod Toxicol 2008; 26:19-23.

2007

Aguilera C, Agustí A.
Low dose of aspirin during pregnancy.
Med Clin (Barc). 2007;128:31-3.

Clementi M, Causin R, Marzocchi C, Mantovani A, Tenconi R.
A study of the impact of agricultural pesticide use on the prevalence of birth defects in northeast Italy
Reproductive Toxicology. 2007: 24: 1-8.

Goldstein LH, Dolinsky G, Grreenberg R, Schaefer C, Cohen-Kerem R, Diav-Citrim O, Malm H, Reuvers-Lodewijks ME, Rost van Tonningen-van Driel MM, Arnon J, Ornoy A, Clementi M, Di Gianantonio E, Koren G, Braunstein R, Berkovitch M.
Pregnancy outcome of women exposed to Azathioprine during Pregnancy
Birth Defects Research (Part A) 2007; 6:701.

Kallinich T, Haffner D, Niehues T, Huss K, Lainka E, Neudorf U, Schaefer C et al.
Colchicine use in children and adolescents with Familial Mediterranean fever. Literature review and consensus statement.
Pediatrics. 2007; 119: e474-83.

Maňáková E, Hubičková Heringová L.
The risks of autoimmune diseases therapy in pregnancy.
Chem Listy. 2007; 101: s122−s125.

Mathieu-Nolf M, Subtil D, Durak-Carpeza C, Couvreux-Dif D, Cartegnie S, Poiteau M, Verrin E
Environmental hazards and pregnancy : potential exposure and expectation of pregnant women. European Teratology Society 33rd Annual Conference 3-7 September 2005, Hotel Haarlem-Zuid, Haarlem, The Netherlands
Reprod Toxicol. 2005; 20(3):471.

Mathieu-Nolf M, Durak-Carpeza C, Mathieu D, Subtil D, Peucelle D.
Pregnancy outcome after suicide attempt by drug ingestion: a nine year prospective study
J. Toxicol Clin. Toxicol. 2005; 43(5):430.

Meister R, Schaefer C.
Spontaneous abortion rates: Unbiased statistical estimation – with coumarins as an example (Abstract).
Reprod Toxicol. 2007; 24: 64.

Ornoy A.
Embryonic oxidative stress as a mechanism of teratogenesis with special emphasis on diabetic embryopathy.
Reproductive Toxicology. 2007; 24(1):31-41.

Ornoy A.
Fetal effects of primary and non-primary cytomegalovirus infection in pregnancy: Are we close to prevention?
IMAJ. 2007; 9(5): 398-401.

Osovsky M, Tamary I, Merlob P.
Neonatal thrombocytosis following G-CSF treatment.
Clin Toxicol. 2007; 45:801-2.

Rahav G, Gabbay G, Ornoy A, Shechtman S, Arnon J, Diav-Citrin O.
Cytomegalovirus in pregnancy – Primary versus non-primary infection: a prospective cohort study.
Emerging Infectious Diseases. 2007; 13(11):1791-1793.

Ramió X, Aguilera C.
Selective serotonin reuptake inhibitor antidepressants in pregnancy.
Med Clin (Barc). 2007;129:194-6.

Schaefer C, Peters PWJ, Miller R (eds).
Drugs during pregnancy and lactation. Treatment options and risk assessment, 2nd ed.
Elsevier/Academic Press, Amsterdam, New York 2007.

2006

Avgil M and Ornoy A.
Herpes simplex virus and Epstein Barr virus infections in pregnancy; consequences of neonatal or intrauterine infection.
Reproductive Toxicology. 2006; 21(4):436-445.

Clementi M.
Introduction 34th Annual Conference of the European Teratology Society
Reproductive Toxicology. 2006; 22:125.

Clementi M, Di Gianantonio E, Ponchia R, Petrella M, Andrisani A, Tenconi R .
Pregnancy outcome after genetic counselling for prenatal diagnosis of unexpected chromosomal anomaly
European Journal of Obstetrics Gynecology Reproductive Biology. 2006; 128: 77-80.

Clementi M, Di Gianantonio Elena.
Therapeutic drug monitoring of antithyroid drugs in pregnancy: the knowledge gaps
Therapeutic Drug Monitoring. 2006; 28:576.

Ergaz Z, Ornoy A.
PARVOVIRUS B19 in pregnancy.
Reproductive Toxicology. 2006; 21(4): 421-435.

Furlan A, Vianello F, Clementi M, Prandoni P.
Heparin- induced thrombocytopenia occurring in the first trimester of pregnancy: successful treatment with lepirudin. A case report
Haematologica/the Hematology . 2006; 91:19-20.

Hubičková Heringová L, Maňáková E.
CZTIS Comparison of the treatment by psychotropic and antiepileptic drugs.
Neuroendocrinology Letters. 2006; 27: (Suppl.2) 74-77.

Klinger G, Levinson-Castiel R, Merlob P.
Neonatal adverse reactions after in utero exposure to selective serotonin reuptake inhibitors: Still controversial.
Arch Pediatr Adolesc Med. 2006; 160:856.

Levinson-Castiel R, Merlob P, Linder N, Sirota L, Klinger G.
Neonatal abstinence syndrome following in utero exposure to selective serotonin reuptake inhibitors in term infants.
Arch Pediatr Adolesc Med. 2006; 160:173-6.

López P, Aguilera C. Med Clin
Safety of antimigraine drugs during pregnancy.
(Barc). 2006;126:793-5.

Martínez-Frías ML, Pérez B, Desviat Lr, Castro M, Leal F, Rodríguez L, Mansilla E, Martínez-Fernández ML, Bermejo E, Rodríguez-Pinilla E, Prieto D, Ugarte M and ECEMC Working Group.
Maternal Polymorphisms 677C-T and 1298-C of MTHFR, and 66A-G MTRR Genes: Is there any relationship between polimorphisms of the folate pathway, maternal homocysteine levels, and the risk for having a child with Down Syndrome? Am J Med Genet (Part A) 2006; 140A:987-997.

Mathieu-Nolf M, Subtil D, Carpeza-Durak C, Couvreux-Dif D, Nisse P
Abstracts of the European Association of Poisons Centres and Clinical Toxicologists XXVI International Congress Volume 44 No. 4 Pages 401 – 586 Environmental hazards and pregnancy: potential exposure and expectation of pregnant woman Clinical Toxicology. 2006; 44:548.

Ostensen M, Khamashta M, Lockshin M, Parke A, Brucato A, Carp H, Doria A, Rai R, Meroni P, Cetin I, Derksen R, Branch W, Motta M, Gordon C, Ruiz-Irastorza G, Spinillo A, Friedman D, Cimaz R, Czeizel A, Piette JC, Cervera R, Levy RA, Clementi M, De Ca.
Anti-inflammatory and immunosuppressive drugs and reproduction
Arthritis Research Therapy. 2006; 8: 209- 318.

Ornoy A, Diav-Citrin O.
Fetal effects of primary and secondary cytomegalovirus infection in pregnancy.
Reproductive Toxicology. 2006; 21(4):399-409.

Ornoy A.
Intrauterine infections: introductory comments.
Reproductive Toxicology. 2006; 21(4):343-344.

Ornoy A.
Neuroteratogens in man: an overview with special emphasis on antiepileptic drugs in pregnancy.
Reprod Toxicol. 2006; 22(8):214-226.

Ornoy A, and Tenenbaum A.
Pregnancy outcome following infections by Coxsackie, Echo, Measles, Mumps, Hepatitis, Polio and Encephalitis viruses.
Reproductive Toxicology. 2006; 21(4):446-457.

Ornoy A, Weijnberg R, Diav-Citrin O.
The outcome of pregnancy following pre-pregnancy or early pregnancy alendronate treatment.
Reproductive Toxicology. 2006; 22:578-579.

Raz-Dubnov G, Shapiro R, Merlob P.
Maternal lamotrigine treatment and elevated neonatal gamma-glutamyl transpeptidase.
Pediatr Neurol. 2006; 35:220-2.

Sharan H, Kaplan B, Weizer N, Sulkes J, Merlob P.
Early screening of postpartum depression using the Edinburgh Postnatal Depression Scale.
Inter J Risk Safety Med. 2006; 19:1-6.

Schaefer C.
Exposure to vitamin K antagonists during pregnancy.
Clin Adv Hematol Oncol. 2006;4:509-10.

Schaefer C, Hannemann D, Meister R, Eléfant E, Paulus W, Vial T, Reuvers M, Robert-Gnansia E, Arnon J, De Santis M, Clementi M, Rodriguez-Pinilla E, Dolivo A, Merlob P.
Vitamin K antagonists and pregnancy outcome
Thrombosis and Haemostasis. 2006; 95: 949-957.

2005

Aguilera C, Izarra A.
Toxic substance abuse during pregnancy.
Med Clin (Barc). 2005;125:714-6.

Bar-Oz B, Clementi M, Giantonio ED, Greenberg R, Beer M, Merlob P, Arnon J, Ornoy A, Zimmerman DM, Berkovitch M.
Metamizol (dipyrone, optalgin) in pregnancy, is it safe? A prospective comparative study.
European Journal of Obstetrics Gynecology Reproductive Biology. 2005; 119:176-9.

Bernat M, Aguilera C.
Treatment of severe hypertension during pregnancy.
MedClin (Barc). 2005;124:634-5.

Benyamini L, Merlob P, Shtahl B, Braunstein R, Bortnik O, Bulkowstein M, Zimmerman D, Berkovitch M.
The safety of the amoxicillin/clavulanic acid and cefuroxime during lactation.
Ther Drug Monit. 2005; 27:499-502.

Botto LD, Lisi A, Robert-Gnansia E, Erickson JD, Vollset SE, Mastroiacovo P, Botting B, Cocchi G, Givan C, Walle H, Feijoo M, Irgens LM, McDonnell B, Merlob P, Ritvanen A, Scarano G, Siffel C, Metneki J, Stoll C, Smithells R, Goujard J.
International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working?
Br Med J. 2005; 330:571-7.

De Santis M, Di Gianantonio E, Straface G, Cavaliere AF, Caruso A, Schiavon F, Berletti R, Clementi M.
Ionizing radiations in pregnancy and teratogeneis – A review of literature
Reproductive toxicology. 2005; 20:323-329.

Depret-Mosser S, Mathieu-Nolf M, Puech F.
What public health measures could reduce antenatal exposure to tobacco and improve the quality of perinatal care: the gynecologist-obstetrician's point of view
J Gynecol Obstet Biol Reprod (Paris). 2005; pr;34 Spec No 1:3S275-8.

Diav-Citrin O, Shechtman S, Ornoy S, Arnon J, Schaefer C, Garbis H, Clementi M, Ornoy A.
Safety of Haloperidol and Penfluridol in Pregnancy: A Multicenter, Prospective, Controlled Study
Journal of Clinical Psychiatry. 2005; 66:317-322.

Diav Citrin O, Arnon J, Shechtman S, Schaefer C, Tonningen MR, Clementi M, Santis M, Robert Gnansia E, Valti E, Malm H, Ornoy A.
The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study
Alimentary Pharmacology and Therapeutics. 2005; 21: 269-275.

Dubnov G, Fogelman R, Merlob P.
Prolonged QT interval in a newborn to a fluoxetine-treated mother.
Arch Dis Child. 2005; 90:972-3.

Garbis H, Elefant E, Diav-Citrin O, Mastroiacovo P, Schaefer C, Vial T, Clementi M, Valti E, McElhatton P, Smorlesi C, Pinilla Rodriguez E, Robert-Gnansia E, Merlob P, PeikeR G, Pexieder T, Schueler L, Ritvanen A, Mathieu-Nolf M.
Pregnancy outcome after exposure to ranitidine and other H2-blockers A collaborative study of the European Network of Teratology Information Services
Reproductive Toxicology. 2005; 19:453-458.

Martínez-Frías ML, Frías JP, Bermejo E, Rodríguez-Pinilla E, Prieto L, Frías JL.
Pre-gestational maternal body mass index predicts and increased risk of congenital malformations in infants of mothers with gestational diabetes.
Diabetic Medicine 2005; 22: 775-781.

Mathieu D, Mathieu-Nolf M.
Physiopathologie de l’intoxication par le monoxyde de carbone
Bull Med. 2005; 15:3-8.

Mathieu D, Wattel F, Mathieu-Nolf M.
Epidémiologie de l’intoxication par le monoxyde de carbone. L’exemple de la région Nord-Pas-de Calais
Bull Med. 2005; 15:37-42.

Mathieu-Nolf M, Subtil D, Durak-Carpeza C, Couvreux-Dif D, Cartegnie S, Poiteau M, Verrin E
Environmental hazards and pregnancy : potential exposure and expectation of pregnant women European Teratology Society 33rd Annual Conference 3-7 September 2005, Haarlem, The Netherlands
Reprod Toxicol. 2005; 20(3):471.

Mathieu-Nolf M, Durak-Carpeza C, Mathieu D, Subtil D, Peucelle D
Pregnancy outcome after suicide attempt by drug ingestion : a nine year prospective study
J. Toxicol Clin. Toxicol. 2005; 43(5):430.

Merlob P, Sapir O, Sulkes J, Fisch B.
The prevalence of major congenital malformations during two periods of time, 1986 - 1994 and 1995 - 2002 in newborns conceived by assisted reproduction technology.
Eur J Med Genet. 2005; 48:5-11.

Ornoy A.
Growth and neurodevelopmental outcome of children born to mothers with pre-gestational and gestational diabetes: An invited review.
Pediatric Endocrinology Reviews. 2005; 3(2): 43-54.

Schaefer C, Hannemann D, Meister R.
Post-marketing surveillance system for drugs in pregnancy – 15 years experience of ENTIS.
Reprod Toxicol. 2005; 20: 331-43.

Tellum R, Shechtman S, Arnon J, Diav-Citrin O, Bar-Oz B, Berkovitch M, Ornoy A.
Pregnancy outcome after gestational exposure to the new macrolides: a prospective controlled cohort study.
Reprod Toxicol. 2005; 20(3): 484-5.

2004

Aguilera C, Danés I, Agustí A.
Therapeutic consultation services about teratology: A growing need for drug information.
Reprod toxicol 2004;19:239-260.

Berkovitch M, Diav-Citrin O, Greenberg R, Cohen M, Bulkowstein M, Shechtman S, Bortnik O, Arnon J, Ornoy A.
First-trimester exposure to amoxycillin/ clavulanic acid: a prospective, controlled study.
Br J Clin Pharmacol. 2004; 58(3):298-302.

Clementi M, ArnonJ, Ornoy A.
Nato advanced research workshop on "Drugs in pregnancy: consensus conference on Teratogen Information Services". Prague, 16-18 April, 2004: Introductory comments.
Reproductive Toxicology. 2004; 19:239-240

Diav- Citrin O, Arnon J, Shechtman S, Wajnberg R, Ornoy A.
Treatment of thyrotoxicosis and hypothyroidism in pregnancy.
Reproductive Toxicology. 2004; 19:243-244

Figueras A, Narváez E, Aguilera C, Laporte JR.
Securing reproductive rights.
Lancet 2004;363:989.

Gur C, Diav-Citrin O, Shechtman S, Arnon J, Ornoy A.
Pregnancy outcome after first trimester exposure to corticosteroids: A prospective controlled study.
Reprod. Toxicol. 2004; 18:93-101.

Jaber L, Karim JA, Jaurdat AM, Fausi M, Merlob P.
Awareness of folic acid for prevention of neural tube defects in a community with high prevalence of consanguineous marriages.
Ann Génétique. 2004; 47:69-75.

Jelínek R.
The contribution of new findings and ideas to the old principles of teratology.
Reproductive toxicology. 2004; 20:295-300.

Martínez-Frías ML, Prieto D, Prieto L, Bermejo E, Rodríguez-Pinilla E, Cuevas L.
Secular decreasing trend of the frequency of hipospadias among newborn male infants in Spain.
Birth Defects Res A Clin Mol Teratol 2004; 70: 75-81.

Martínez-Frías ML, Bermejo E, Rodríguez-Pinilla E, Frías JL.
Risk for congenital anomalies associated with different sporadic and daily doses of alcohol consumption during pregnancy: a case-control study.
Birth Defects Research (Part A) 2004; 70: 194-200.

Mathieu-Nolf M, Durak-Carpeza C, Mathieu D, Subtil D, Peucelle D
Conséquences d’une intoxication médicamenteuse volontaire pendant la grossesse.
Annales de Toxicologie Analytique. 2004;16:149-150.

Mathieu-Nolf M, Durak-Carpeza C, Mathieu D, Subtil D, Peucelle D
Pregnancy outcome after suicide attempt by drug ingestion : a nine-year prospective study.
Reprod Toxicol. 2004; 19(2):257-258.

Mendoza G, Aguilera C.
Safety of antipsychotic drug during pregnancy.
Med Clin (Barc). 2004;122:475-6.

Merlob P.
Drug exposure during pregnancy: Pharmaceutical advertising.
Reprod Toxicol. 19:260.

Merlob P.
Infants of mothers with malignant disease (IMMD).
Reprod Toxicol. 2004; 19:251.

Merlob P, Stahl B, Sulkes J.
Paroxetine during breast-feeding: infant weight gain and maternal adherence to counsel.
Eur J Pediatr. 2004; 163:135-9.

Ornoy A, Arnon J, Shechtman S, Diav- Citrin O.
The developmental effects of maternal antiepileptic drugs with special emphasis on carbamazepine.
Reproductive Toxicology. 2004; 19:248-249.

Ratzon N , Ornoy A, Pardo A, Margolin R, Hatch M.
Developmental evaluation of children born to mothers occupationally exposed to waste anesthetic gases.
Birth Defects Research, Part A, Clinical and Molecular Teratology. 2004; 70:476-482.

Rebordosa C, Aguilera C.
Safety of antiepileptic drugs during pregnancy.
Med Clin (Barc). 2004;122:675-6.

Schaefer C.
Are new anticonvulsants safer than classical? (Abstract).
Reprod Toxicol. 2004; 19: 247-8.

Schaefer C.
Major birth defects and classical anticonvulsants – How to resume the risk? (Abstract)
Reprod Toxicol. 2004; 19: 244-5.

2003

Aguilera C, Agustí A.
Anticoagulation of pregnant women with mechanical heart valves.
Med Clin (Barc). 2003;121:755-6.

Aguilera C, Agustí A.
Safety of glucocorticoid administration during pregnancy.
Med Clin (Barc). 2003;120:395-6.

Bar J, Stahl B, Hod M, Wittenberg C, Pardo J, Merlob P.
Is immunosuppression therapy in renal allograft recipients teratogenic? A single-center experience.
Am J Med Genet. 2003; 116A:31-6.

Clementi M, Giavini E, Mantovani A.
Avoidance of bioflavonoid supplements during pregnancy
The Lancet. 2003; 361:261-262.

Diav-Citrin O, Shechtman S, Aharonovich A, Moerman L, Arnon J, Wajnberg R, Ornoy A.
Pregnancy outcome after gestational exposure to loratadine or antihistamines: a prospective controlled cohort study.
J. Allergy Clin. Immunol. 2003; 111:1239-1243.

Diav-Citrin O, Shechtman S, Arnon J, Lubart I, Ornoy A.
Pregnancy outcome after gestational exposure to mebendazole: a prospective controlled cohort study.
Am. J. Obstet. Gynecol. 2003; 188:282-285.

Merlob P, Sharan H, Weiss S.
Maternal report of prenatal alcohol use.
Pediatrics. 2003; 111:443-4.

Naor N, Merlob P.
To dye or not to dye: A randomized, clinical trial of a triple dye-alcohol regime versus dry cord care.
Pediatrics. 2003; 112:2001.

Heringová L, Jejínek R, Dostál M.
Cell-cycle alterations underlie cyclophosphamide-induced teratogenesis in the chick embryos.
Birth Defects Research. Part A: Clinical and Molecular Teratology. 2003; 67: 438-443.

Schaefer C.
Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicity.
Birth Defects Research A 2003; 67:591-4.

2002

Clementi M, Di Gianantonio E, Ornoy A.
Teratology information services in europe and their contribution to the prevention of congenital anomalies.
Community Genetics. 2002; 5: 5-7.

Martínez-Frías ML, Rodríguez-Pinilla E, Bermejo E, Prieto L.
Epidemiological Evidence that maternal diabetes does not appear to increase the risk for Down Syndrome.
Am J Med Genet 2002; 112:335-337.

2001

Di Gianantonio E, Schaefer C, Mastroiacovo PP, Cournot MP, Benedicenti F, Reuvers M, Occupati B, Robert E, Bellemin B, Addis A, Arnon J, and Clementi M.
Adverse effects of prenatal methimazole exposure
Teratology. 2001; 64: 262-266.

Garne E, Stoll C, Clementi M, and Euroscan group.
Evaluation of Prenatal Diagnosis of Congenital Heart Diseases by Ultrasound: Experience from 20 European Registries
Ultrasound in Obstetrics and Gynecology. 2001; 17: 386-391.

Martínez-Frías ML, Rodríguez-Pinilla E.
Epidemiologic analysis of prenatal exposure to cough medicines containing dextromethorphan: no evidence of human teratogenicity.
Teratology 2001; 63:38-41.

2000

Martínez-Frías ML, Bermejo E, Rodríguez-Pinilla E, Prieto L.
Case- control study of maternal occupation as hairdresser during pregnancy and congenital defects.
Environmental Epidemiology and Toxicology 2000; 2:20-23.

Rodríguez-Pinilla E, Arroyo I, Fondevilla J, García MJ, Martínez-Frías ML.
Prenatal exposure to Valproic Acid during pregnancy and limb deficiencies: a case-control study.
Am J Med Genet 2000; 90:376-381.

1999

Clementi M, Di Gianantonio E, Pelo E, Mammi I, Tenconi R.
Methimazole embryopathy. Delineation of the phenotype
American Journal of Medical Genetics. 1999; 83:43-46.

Martínez-Frías ML, Bermejo E, Rodríguez-Pinilla E, Prieto L.
Exploratory case-control study on maternal occupation as cook during pregnancy and congenital defects.
Environmental Epidemiology and Toxicology 1999; 1:148-152.

Martínez-Frías ML, Bermejo E, Rodríguez-Pinilla E, Frías JL.
Maternal and fetal factors related to abnormal amniotic fluid.
Journal of Epidemiology 1999; 19 (7):514-520.

Mastroiacovo P, Mazzone T, Addis A, Elephant E, Carlier P, Vial T, Garbis H, Robert E, Bonati M, Ornoy A, Finardi A, Schaffer C, Caramelli L, Rodriguez-Pinilla E, Clementi M.
High vitamin A intake in early pregnancy and major malformations: a multicenter prospective controlled study
Teratology . 1999; 59: 7-11.